12-Month Lobbying Summary - Consultant Lobbyist
The Canadian Forum for Rare Disease Innovators (RAREi) / Steve Vander Wal, Consultant Lobbyist
Registration Summary
Currently active
-
New Activity Effective:
2026-03-06
Who is lobbying?
The Canadian Forum for Rare Disease Innovators (RAREi) (Address & business activities)
Government Funding
Did The Canadian Forum for Rare Disease Innovators (RAREi) receive government funding within the last 12 months? No
Other Entities (working together for the purposes of lobbying) Information
The Canadian Forum for Rare Disease Innovators (RAREi) is working together with the following other entities for the purpose of lobbying:
- Alexion Pharma Canada Corp. (Address information)
- Amgen Canada Inc (Address information)
- Amicus Therapeutics Canada Inc. (Address information)
- Argenyx Canada (Address information)
- Biogen Canada (Address information)
- Biomarin Pharmaceuticals Inc. (c/o Mark Bennett, Cassels Brock) (Address information)
- Ipsen Pharmaceuticals Canada Inc. (Address information)
- Johnson & Johnson Innovative Medicine (Address information)
- Medison Pharma Canada Inc. (Address information)
- PTC Therapeutics Canada ULC (Address information)
- Recordati Rare Disease Canada Inc. (Address information)
- Sanofi Canada Inc. (Address information)
- Sobi Canada Inc. (Address information)
- Tanabe Pharma Canada (Address information)
- UCB Canada Inc. (Address information)
- Ultragenyx Canada Inc. (Address information)
- Vertex Pharmaceuticals (Canada) Inc. (Address information)
Direct Interests of the Lobbying Activity
Affiliates
The Canadian Forum for Rare Disease Innovators (RAREi) does not have any affiliates that could have a direct interest in the outcome of the lobbying activities
Other Affiliates
The activities of The Canadian Forum for Rare Disease Innovators (RAREi) are not controlled or directed by another person or organization with a direct interest in the outcome of this undertaking
Contributors with a Direct Interest in the Outcome
No person or organization contributed over $1000CDN, within the preceding 12 months, toward the lobbying activity on behalf of The Canadian Forum for Rare Disease Innovators (RAREi):
What is being lobbied?
Details Regarding the Identified Subject Matter |
|||||||
| Will the consultant lobbyist be arranging meetings between a public office holder and the client for the purpose of attempting to influence any of the matters listed: | Yes | ||||||
|
|||||||
Gifts or Benefits Provided to Public Officer Holders
Lobbyists are required to provide information regarding gifts or benefits provided within the last 12 months to a public office holder they have lobbied. For more information, review the Guide to Lobbyist Gifts.
| Name | Gift or Benefit Description | Circumstance | Date Promised | Value Promised | Date Given | Value Given |
|---|---|---|---|---|---|---|
| No Records | ||||||
Who is being lobbied?
Ministries/Provincial Entities
- Health
- Office of the Premier
Who is the lobbyist?
Steve Vander Wal, Consultant Lobbyist (Business address and contact information)
- Payment to the consultant lobbyist by the client, in whole or in part, is not contingent on the outcome of this lobbying activity.
- Payment to the consultant lobbyist by the client, in whole or in part, is not contingent on the success in arranging a meeting with public office holders on behalf of the client.
Who has provided contributions?
| Consultant has lobbied, or plans to lobby a member of the Legislative Assembly, including a Minister or Premier, on behalf of this client, on or after 2024-09-21: |
No
Contributions information is not required |
Contributions information is not required to be answered until a Lobbying Activity Report has been entered.
Lobbying Activity Reports
What lobbying activities have taken place in the last 12 months?
| Date | Arranging a Meeting | Senior Public Office Holder, Position Title | Ministry/Provincial Entity | Subject Matters |
|---|---|---|---|
| 2026-03-06 | Yes |
|
View |
- Date Modified: